NCT01508221View on ClinicalTrials.gov

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Brain Metastasis
Interventions
DRUG

Trental

400 mg tid starting first day after last radiosurgery treatment and continuing for 6 months

DIETARY_SUPPLEMENT

Vitamin E

400IU twice daily starting the first day after last radiosurgery treatment and continuing for 6 months

Trial Locations (1)

45219

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT01508221 - Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis | Biotech Hunter | Biotech Hunter